FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 127 filers reported holding FLEXION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $908,000 | -20.3% | 148,855 | +7.6% | 0.00% | – |
| Q2 2021 | $1,139,000 | -24.6% | 138,297 | -18.1% | 0.00% | – |
| Q1 2021 | $1,511,000 | -23.6% | 168,821 | -1.5% | 0.00% | – |
| Q4 2020 | $1,977,000 | +12.1% | 171,358 | +1.2% | 0.00% | – |
| Q3 2020 | $1,763,000 | -11.8% | 169,323 | +11.4% | 0.00% | -100.0% |
| Q2 2020 | $1,999,000 | -62.9% | 151,992 | -77.8% | 0.00% | -50.0% |
| Q1 2020 | $5,391,000 | -75.3% | 685,070 | -35.1% | 0.00% | -66.7% |
| Q4 2019 | $21,862,000 | -3.2% | 1,056,084 | -35.9% | 0.01% | 0.0% |
| Q3 2019 | $22,582,000 | +19.8% | 1,647,699 | +7.6% | 0.01% | +20.0% |
| Q2 2019 | $18,842,000 | +4.5% | 1,531,879 | +6.1% | 0.01% | 0.0% |
| Q1 2019 | $18,026,000 | -2.2% | 1,444,368 | -11.3% | 0.01% | -16.7% |
| Q4 2018 | $18,439,000 | -63.7% | 1,628,796 | -40.1% | 0.01% | -53.8% |
| Q3 2018 | $50,833,000 | -27.7% | 2,716,953 | -0.1% | 0.01% | -31.6% |
| Q2 2018 | $70,328,000 | +18.4% | 2,720,648 | +2.6% | 0.02% | +18.8% |
| Q1 2018 | $59,412,000 | -14.5% | 2,651,140 | -4.4% | 0.02% | -11.1% |
| Q4 2017 | $69,453,000 | +10.5% | 2,773,686 | +6.7% | 0.02% | +5.9% |
| Q3 2017 | $62,837,000 | +14.4% | 2,598,707 | -4.3% | 0.02% | +13.3% |
| Q2 2017 | $54,921,000 | -3.9% | 2,716,189 | +27.9% | 0.02% | -6.2% |
| Q1 2017 | $57,163,000 | +54.3% | 2,124,208 | +9.0% | 0.02% | +45.5% |
| Q4 2016 | $37,056,000 | +16.3% | 1,948,329 | +19.4% | 0.01% | +22.2% |
| Q3 2016 | $31,876,000 | +33.6% | 1,631,323 | +2.3% | 0.01% | +28.6% |
| Q2 2016 | $23,855,000 | +167.3% | 1,594,026 | +64.3% | 0.01% | +133.3% |
| Q1 2016 | $8,926,000 | -18.6% | 970,263 | +70.5% | 0.00% | 0.0% |
| Q4 2015 | $10,964,000 | +1568.8% | 568,976 | +1185.7% | 0.00% | – |
| Q3 2015 | $657,000 | -43.4% | 44,253 | -16.5% | 0.00% | – |
| Q2 2015 | $1,160,000 | +62.5% | 52,982 | +67.2% | 0.00% | – |
| Q1 2015 | $714,000 | +72.5% | 31,693 | +54.4% | 0.00% | – |
| Q4 2014 | $414,000 | +18.3% | 20,526 | +6.9% | 0.00% | – |
| Q3 2014 | $350,000 | -32.7% | 19,198 | -50.2% | 0.00% | – |
| Q2 2014 | $520,000 | +209.5% | 38,522 | +277.2% | 0.00% | – |
| Q1 2014 | $168,000 | – | 10,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
| Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
| Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
| GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
| MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
| PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
| Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |